India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Aurigene.AI is an end-to-end solution for small molecule drug discovery
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
